Skip to content

Precigen PGEN Operating margin

Operating margin at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.3%-2.9pp
Gilead Sciences logo
Gilead SciencesGILD
34.9%+6.3pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-543.9%-271pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-720%-204pp
Arrowhead Research logo
Arrowhead ResearchARWR
-35.7%+63.6pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-83.8%-3.0pp

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Based on trailing twelve months.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's operating margin?
Precigen (PGEN) reported operating margin of -2,890.9% in Q1 2025.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.